Initial Stockholders News Today

Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension

ROTH CH ACQUISITION V CO. 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 SUPPLEMENT NO. 2 TO PROXY STATEMENT DATED...

ROTH CH ACQUISITION V CO. 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 SUPPLEMENT TO PROXY STATEMENT DATED NOVEMBER...

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and Board of Directors of Four Leaf Acquisition Corporation ...

ALS biomarker and long-term clinical data expected mid-yearNeurology expert Ben Greenberg, M.D., M.H.S., joined as Head of Medical SALT LAKE CITY, May ...

Rye Brook, New York, March 31, 2023 -- Schultze Special Purpose Acquisition Corp. II today announced further actions being undertaken in anticipation of the previously announced special meeting... | March 31, 2023

(2022-05-09 | NDAQ:CLNN) Clene Reports First Quarter 2022 Financial Results and Recent Operating Highlights

Press release content from Globe Newswire. The AP news staff was not involved in its creation.